Discover other firms ranked in Capital Markets: Equity

2
Band 2
Freshfields
2
Freshfields
13 Years Ranked

View profile
A&O Shearman
2
A&O Shearman
25 Years Ranked

View profile
Simpson Thacher & Bartlett LLP
2
Simpson Thacher & Bartle…
13 Years Ranked

View profile
3
Band 3
Milbank LLP
3
Milbank LLP
12 Years Ranked

View profile
Baker McKenzie
3
Baker McKenzie
13 Years Ranked

View profile
Sullivan & Cromwell LLP
3
Sullivan & Cromwell LLP
13 Years Ranked

View profile
4
Band 4
Paul Hastings LLP
4
Paul Hastings LLP
13 Years Ranked

View profile
Morrison Foerster
4
Morrison Foerster
13 Years Ranked

View profile

Chambers Review

Provided by Chambers
Capital Markets: Equity - Asia-Pacific Region
3
Band 3
What the team is known for

Kirkland & Ellis offers a highly active ECM practice, much admired for its consistency and visibility on high-profile deals. The team has a strong track record of acting for international and local businesses and investment banks on US and Hong Kong IPOs. It additionally handles a range of secondary offerings in Hong Kong and New York and maintains strong relationships with regulators. As a Hong Kong and New York-qualified team with Chinese language capabilities, Kirkland & Ellis is well placed to advise on listings on a variety of stock exchanges. It often advises on significant deals in China's TMT and life sciences sectors.

Strengths

"Commercial savviness is a strength; they are very commercially attuned to the business drivers of a transaction."

Work highlights

Kirkland & Ellis advised Yunkang Group on its USD140 million global offering and listing on The Stock Exchange of Hong Kong.

Notable practitioners

Hong Kong-based David Zhang and Lu Mengyu are key contacts for the group.